IBM Q2 preview miss prompts analysts to cut estimates on softer demand

IBM’s preliminary Q2 results came in below expectations: revenue was $17.2B vs $17.9B consensus and adjusted EPS was $2.93 vs $3.02. Bank of America and UBS pointed to weaker software and infrastructure demand, with customers shifting capital spending priorities and delaying large deals. The outlook pressure is likely to weigh on near-term sentiment as analysts recalibrate growth assumptions.

Analysis

IBM’s miss is more important as a read-through on enterprise IT budget allocation than as a one-quarter event. The weak point is not just revenue; it suggests customers are prioritizing short-cycle, ROI-visible spend and deferring multi-quarter transformation deals, which tends to punish vendors with a heavier mix of large, negotiated contracts and maintenance-heavy revenue streams. That dynamic usually compresses forward multiples first, then shows up in lower renewal leverage and weaker backlog conversion over the next 1-3 quarters.

Second-order losers are the adjacent infrastructure stack: HPE, DELL, and parts of CSCO can feel pressure if enterprise refresh cycles are slipping, while consulting-heavy peers face slower project starts and more aggressive procurement scrutiny. The relative winners are vendors with faster budget capture and clearer AI/cloud payback, especially MSFT, ORCL, and to a lesser extent AMZN on the infrastructure side, because CIOs tend to reallocate rather than expand total spend in this environment. If IBM’s softness is driven by deal deferrals rather than demand destruction, the impact is mostly timing; if it reflects a broader freeze, it becomes a sector-wide multiple issue.

The contrarian view is that the market may be underestimating how quickly IBM can stabilize if deferred deals close into the next quarter, especially given its recurring software mix. That makes this more of a “prove it” setup than a structural short unless management confirms that the weakness is pipeline conversion rather than temporary slippage. The key falsifier is a re-acceleration in software growth or commentary that large-deal bookings normalized; absent that, expect continued de-rating over 1-3 months and a slower rebuild in 6-18 months.

Key Decisions for Investors

• Short IBM on any relief rally; use a 4-8 week horizon and size for a 10-15% downside move if management does not restore confidence on software bookings or deal timing.
• Pair trade: long MSFT or ORCL vs short IBM for the next 1-3 months; the thesis is that budget dollars will migrate toward vendors with clearer AI/cloud monetization and better conversion of deferred spend.
• Watch HPE and DELL as secondary shorts if enterprise infrastructure weakness broadens; confirm with subsequent commentary on server/storage order rates before initiating.
• Do not force a long BAC trade; its relevance is signaling, not fundamental exposure. Use it only as a read-through on broader enterprise credit and spending tone.
• Falsifier/alert: if IBM reaffirms full-year software growth or large-deal backlog improves next quarter, cover shorts quickly; the trade thesis weakens materially if deferred deals are merely timing shifts.